NutraLife BioSciences Inc. (NLBS)
| Market Cap | 13.39M |
| Revenue (ttm) | 2.81M |
| Net Income (ttm) | -3.29M |
| Shares Out | 134.24M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $0.0951 |
| Previous Close | $0.1100 |
| Change ($) | -0.0150 |
| Change (%) | -13.55% |
| Day's Open | 0.1100 |
| Day's Range | 0.0950 - 0.1100 |
| Day's Volume | 9,975 |
| 52-Week Range | 0.028 - 0.18 |
News
There are no news available yet.
About NLBS
NutraLife BioSciences, together with its subsidiaries, develops, manufactures, and distributes nutraceutical, wellness, and cannabidoil (CBD) products. It offers NutraHemp CBD products, including oral sprays, tinctures, pet drops, pain balms, and face creams; NutraSpray oral spray products for sleep support and weight loss; and an appetite suppressant. The company also provides cannabinoid-rich hemp oil, topical lotions and oils, massage oils, and internal pet products. It offers its products to private label distributors. The company offers pr... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | Founded 2010 |
| CEO Edgar Ward | Employees 25 |
| Stock Exchange OTCMKTS | Ticker Symbol NLBS |
Financial Performance
In 2018, NLBS's revenue was $3.71 million, an increase of 107.32% compared to the previous year's $1.79 million. Losses were -$2.07 million, -91.22% less than in 2017.